Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice

被引:0
作者
Nicole Fadahunsi
Jens Lund
Alberte Wollesen Breum
Cecilie Vad Mathiesen
Isabella Beck Larsen
Gitte Moos Knudsen
Anders Bue Klein
Christoffer Clemmensen
机构
[1] University of Copenhagen,Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences
[2] Copenhagen University Hospital,Neurobiology Research Unit
[3] University of Copenhagen,Faculty of Health and Medical Sciences
来源
Translational Psychiatry | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Psilocybin and other serotonergic psychedelics have re-emerged as therapeutics for neuropsychiatric disorders, including addiction. Psilocybin induces long-lasting effects on behavior, likely due to its profound ability to alter consciousness and augment neural connectivity and plasticity. Impaired synaptic plasticity in obesity contributes to ‘addictive-like’ behaviors, including heightened motivation for palatable food, and excessive food seeking and consumption. Here, we evaluate the effects of psilocybin on feeding behavior, energy metabolism, and as a weight-lowering agent in mice. We demonstrate that a single dose of psilocybin substantially alters the prefrontal cortex transcriptome but has no acute or long-lasting effects on food intake or body weight in diet-induced obese mice or in genetic mouse models of obesity. Similarly, sub-chronic microdosing of psilocybin has no metabolic effects in obese mice and psilocybin does not augment glucagon-like peptide-1 (GLP-1) induced weight loss or enhance diet-induced weight loss. A single high dose of psilocybin reduces sucrose preference but fails to counter binge-like eating behavior. Although these preclinical data discourage clinical investigation, there may be nuances in the mode of action of psychedelic drugs that are difficult to capture in rodent models, and thus require human evaluation to uncover.
引用
收藏
相关论文
共 293 条
  • [1] Volkow ND(2013)Obesity and addiction: neurobiological overlaps Obes Rev 14 2-18
  • [2] Wang G-J(2005)How can drug addiction help us understand obesity? Nat Neurosci 8 555-60
  • [3] Tomasi D(2018)Persistent effects of obesity: a neuroplasticity hypothesis Ann NY Acad Sci 1428 221-39
  • [4] Baler RD(2004)Structural plasticity associated with exposure to drugs of abuse Neuropharmacology 47 33-46
  • [5] Volkow ND(2017)Obesity-induced structural and neuronal plasticity in the lateral orbitofrontal cortex Neuropsychopharmacol 42 1480-90
  • [6] Wise RA(2015)Genetic studies of body mass index yield new insights for obesity biology Nature 518 197-206
  • [7] Matikainen-Ankney BA(2020)Psychedelic psychiatry’s brave new world Cell 181 24-8
  • [8] Kravitz AV(2019)Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Neuropsychopharmacol 44 1328-34
  • [9] Robinson TE(2018)Psychedelics promote structural and functional neural plasticity Cell Rep 23 3170-408
  • [10] Kolb B(2018)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Psychopharmacology 235 399-49